Ex Parte EL-Naggar et al - Page 1
Legal Research Home >
Board of Patent Appeals and Interferences > 2007 > Ex Parte EL-Naggar et al - Page 1
The opinion in support of the decision being entered today
is not binding precedent of the Board.
UNITED STATES PATENT AND TRADEMARK OFFICE
BEFORE THE BOARD OF PATENT APPEALS
Ex parte MAWAHEB M. EL-NAGGAR and AHMED S. MOUSA
Technology Center 1600
Decided: September 20, 2007
Before ERIC GRIMES, LORA M. GREEN, and RICHARD M.
LEBOVITZ, Administrative Patent Judges.
GRIMES, Administrative Patent Judge.
DECISION ON APPEAL
This is an appeal under 35 U.S.C. § 134 involving claims to a
composition and method for treating inflammatory disorders. The Examiner
has rejected the claims as obvious. We have jurisdiction under 35 U.S.C.
§ 6(b). We reverse.
“One of the most adverse effects of nonsteroidal anti-inflammatory
drugs (NSAIDs) is their ulcerogenic activity on the gastrointestinal tract”
Page: 1 2 3 4 5 6 7 8 9
Last modified: November 3, 2007